111 Capital’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
111 Capital's EXEL Position: Q2 2026 in Review
111 Capital reduced its Exelixis (EXEL) stake by 41% in Q2 2026, selling an estimated $157K and leaving 4,651 shares worth $253K. The position accounts for 0.04% of the portfolio, ranked #402.
111 Capital first reported a position in EXEL in Q2 2025 and has held it in 4 quarters since. The position peaked at $338K in Q1 2026. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- 111 Capital held 4,651 shares of Exelixis worth $253K as of Q2 2026.
- 111 Capital sold 3,233 Exelixis shares in Q2 2026, an estimated $157K.
- Exelixis made up 0.04% of 111 Capital's portfolio in Q2 2026, its #402 holding.
- 111 Capital first reported a position in Exelixis in Q2 2025 and has held it in 4 quarters since.
- 111 Capital's Exelixis position peaked at $338K in Q1 2026.
- 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.